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Abstract
Background: The goal of the study is to investigate 18F-fluorodeoxyglucose positron emission tomography
(18F-FDG-PET)’s ability to delineate the viable portion of a tumor in an animal model using cross-sectional histology
as the validation standard.
Methods: Syngeneic mammary tumors were grown in female Lewis rats. Macroscopic histological images of the
transverse tumor sections were paired with their corresponding FDG micro-PET slices of the same cranial-caudal
location to form 51 pairs of co-registered images. A binary classification system based on four FDG-PET tumor
contouring methods was applied to each pair of images: threshold based on (1) percentage of maximum tumor
voxel counts (Cmax), (2) percentage of tumor peak voxel counts (Cpeak), (3) multiples of liver mean voxel counts
(Cliver) derived from PERCIST, and (4) an edge-detection-based automated contouring system. The sensitivity, which
represented the percentage of viable tumor areas correctly delineated by the gross tumor area (GTA) generated
from a particular tumor contouring method, and the ratio (expressed in percentage) of the overestimated areas
of a gross tumor area (GTAOE)/whole tumor areas on the macroscopic histology (WTAH), which represented
how much a particular GTA extended into the normal structures surrounding the primary tumor target, were
calculated.
Results: The receiver operating characteristic curves of all pairs of FDG-PET images have a mean area under the
curve value of 0.934 (CI of 0.911–0.954), for representing how well each contouring method accurately delineated
the viable tumor area. FDG-PET single value threshold tumor contouring based on 30 and 35 % of tumor Cmax or
Cpeak and 6 × Cliver + 2 × SD achieved a sensitivity greater than 90 % with a GTAOE/WTAH ratio less than 10 %.
Contouring based on 50 % of Cmax or Cpeak had a much lower sensitivity of 67.2–75.6 % with a GTAOE/WTAH ratio
of 1.1–1.7 %. Automated edge detection was not reliable in this system.
Conclusions: Single-value-threshold tumor contouring using 18F-FDG-PET is able to accurately delineate the
viable portion of a tumor. 30 and 35 % of Cmax, 30 and 35 % of Cpeak, and 6 × Cliver + 2 × SD are three appropriate
threshold values to delineate viable tumor volume in our animal model. The commonly used threshold value of
50 % of Cmax or Cpeak failed to detect one third of the viable tumor volume in our model.
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Background
18F-FDG-PET can identify local and disseminated malig-
nant lesions and help separate tumor from surrounding
normal tissue. Accurate tumor delineation based on
FDG-PET imaging is crucial for PET based radiotherapy
planning. A key issue is to determine how to best delin-
eate the tumor/non-tumor margin from FDG-PET im-
ages. In general, the contouring methods used in these
studies can be grouped into several approaches: “top-
down,” “bottom-up,” “source-to-background ratio,” or
“edge detection” [1–6].
In a top-down approach, a fixed percentage of the
highest tumor standard uptake value (SUV) is applied to
the FDG-PET image. Fifty percent of the maximum
SUV in the tumor was reported as the best threshold for
delineation of non-small cell lung cancer (NSCLC) tu-
mors by Wu et al. [2]. Erdi et al. suggested 42 % of the
maximum tumor uptake intensity as a proper contour-
ing value in phantom studies [3]. Using a technique
similar to Erdi’s, van Baardwijk et al. obtained a signifi-
cant correlation between FDG-PET volume and histo-
pathological measurements for 23 NSCLC tumors [4].
In a bottom-up approach, tumor delineation is based
on normal tissue or the background SUV. Zasadny et al.
used a bottom-up approach in lung cancer, where they
selected FDG-PET voxel intensities that were over three
times the standard deviation above the intensity of the
normal lung background as the target tumor volume [5].
Finally, broadly based on edge detection, several insti-
tutions have investigated their own computerized algo-
rithms derived from mathematical models. Hatt et al.
have developed a fuzzy locally adaptive Bayesian algo-
rithm to compare maximum diameters of delineated
volumes on FDG-PET to a histopathological sample [7].
Some studies have left the decision of how to delineate
tumor volume in the hands of radiation oncologists and
nuclear medicine physicians, using FDG-PET adjunc-
tively to improve the accuracy of tumor volume deter-
mined from CT, especially to separate normal tissues
from tumor [8].
Another important issue in PET based radiotherapy
planning is to determine whether 18F-FDG-PET imaging
can delineate the viable portion of a heterogeneous
tumor from the necrotic portion. The validation stan-
dards reported in the literature are too simplified to ad-
equately address this aspect of FDG-PET imaging [6]. In
most clinical studies, surgical specimens were used as
the “gold standard”, and results derived from the tumor
contouring methods were compared to the external di-
mensions of the surgical specimen. There are two major
drawbacks to such a validation standard. First, tumors
are usually irregularly shaped, which makes a compari-
son in dimensions quite coarse. Second, a tumor speci-
men’s outer dimensions provide no information about
the tumor’s internal biological heterogeneity. Tumors of
similar dimensions may have different internal distribu-
tions of viable tumor tissues, and there are only a few
studies taking into account such biological variation [8].
Tumors may shrink during histological processing, which
further complicates the overall validation process [9].
The purpose of our study was to design a validation sys-
tem for FDG-PET tumor contouring method using corre-
sponding cross-sectional pathology based on frozen tumor
sections as the gold standard. We also investigated FDG-
PET’s ability, using several analytical approaches, to dem-
onstrate a tumor’s internal heterogeneous distribution of
viable tumor tissues in addition to delineation of the total
tumor volume. We would like to quantify the viable and
necrotic regions within a tumor to facilitate animal radio-
therapy planning studies seeking dose efficiency and re-
duction or tumor necrosis targeted radiotherapy [10, 11].
Methods
This project was approved by the animal care commit-
tee. IRB approval was not obtained because this was a
pre-clinical study and no human subjects or tissues were
involved.
Tumor model
Carcinogen-induced rat mammary tumor line was se-
lected as the animal model due to their known hetero-
geneity and syngeneic nature, allowing them to grow in
rodents with a competent immune system [12, 13]. Sus-
pension containing approximately 106 cells was sequen-
tially propagated in vivo by implanting them in the
scapular fat pad region of female Lewis rats (purchased
from Charles River Laboratories). The animal models in
our experiment were established from three consecutive
generations of propagations in a total of nine Lewis rats.
Tumor imaging
Rats with mammary tumors were prepared for FDG-
PET imaging when the tumors reached at least 3 cm in
diameter in about 2–3 weeks. Tumor-bearing rats were
shaved in the scapular area and fasted the night before
imaging with a Philips MOSAIC Animal PET Imaging
System [14]. To maintain identical anatomical orienta-
tions during tumor imaging and tumor specimen pro-
cessing, a stand-alone rat bed was constructed in the
same shape as the animal PET scanner imaging bed.
On the day of imaging, tumor-bearing rats were anes-
thetized with 1 % isoflurane. 3.7 × 107 Bq (1 m Ci) of
18F-FDG (P.E.T.Net, Glen Burnie, MD, USA) was
injected through a tail vein. After radiotracer injection,
the rat was kept warm for a 1-h uptake period until im-
aging and then placed in the imaging bed in the prone
position, sedated, with the tumor on its back positioned
upright.
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Using the PET scanner’s integrated laser positioning
system, 3–5 transverse sectioning positions were identi-
fied and marked in each rat. At each sectioning position,
the skin over the tumor was marked and the imaging
bed position recorded. In order to facilitate accurate
translational and rotational imaging registration, two fi-
ducial markers with 18F-FDG were placed at each trans-
verse sectioning line (Fig. 1a). In order to reconstruct
the attenuation corrected FDG-PET images, a transmis-
sion scan was performed before the PET scan. The static
PET imaging acquisition lasted for 30 min.
The FDG-PET images were reconstructed using three-
dimensional row-action maximum-likelihood algorithm
on a 128 × 128 × 120 matrix, where the voxel size equals
1 mm3. Attenuation was corrected using a 137Cs single
photon transmission measurement. Decay correction,
normalization, dead time correction, and scatter correc-
tion were also utilized [12].
Tumor processing
After imaging, the rat was humanely sacrificed in the
imaging bed by gas anesthesia overdosing, with its im-
aging position maintained. It was then carefully trans-
ferred to the identical rat bed with its anatomical
orientation preserved. The whole rat and its rat bed were
quickly frozen using dry ice and transferred to a −20 °C
freezer. In the following 2–3 h, the whole rat was
allowed to freeze to the extent where the necrotic por-
tion of the tumor was solidified but could still be sliced
into transverse sections with relative ease.
We had a device specially designed to allow easy and
accurate sectioning of the rat along its skin markings, so
that the sectioning planes parallel to the axial planes of
the FDG-PET images. The tumor-containing portion of
each rat was sectioned transversely into three to five
blocks, and each sectioning resulted in a rostral and a
caudal cross-sectional surfaces. In order to preserve the
anatomical configuration, the blocks were sectioned at a
sufficient thickness (6–8 mm) to prevent block deform-
ity from the shearing force of sectioning. All blocks were
stored in an airtight box to avoid moisture and kept in
the freezer overnight (Fig. 1b). All cross-sectional sur-
faces were imaged at a visible light wavelength and digi-
tized using a flat panel color scanner with a resolution
of 200 dots per inch (DPI). These images are the macro-
scopic histological images of tumor blocks.
Rats 1–8 were processed in the method described
above, and a total of 51 technically adequate macro-
scopic histological images were acquired from eight rats.
Rat 9, serving as a reference rat, was processed differ-
ently. After it was sacrificed on the imaging bed, we har-
vested its tumor, submerged the tumor specimen in
10 % formalin, and sent it for hematoxylin and eosin
(H&E) staining and microscopic histology.
Image data processing
There were two categories of image data to be proc-
essed: (1) Macroscopic histological images generated
from cross-sectional surfaces of the frozen tumor blocks,
as demonstrated in Fig. 1b and Fig. 2a. (2) The recon-
structed FDG-PET imaging slices of the same tumor at
the identical cranial-caudal level as the histological im-
ages from the first category of data, as demonstrated in
Fig. 2b.
A note needed to be made on the comparison between
the macroscopic histological image and the FDG-PET
image. Each FDG-PET slice represented a three-
dimensional (3D) distribution of radioactivity. Ideally,
the corresponding histological gold standard should have
been a very thin piece of 3D tissue block of the same
thickness, and the comparison should have been made
in volume instead of area. However, to produce a tissue
block of 1-mm thickness and measure its viable and nec-
rotic volumes is technically difficult. Instead, we used
Fig. 1 Tumor processing. a The rat was anesthetized, transverse markings were drawn across the tumor (circled in yellow), and fiducial markers
(white squares) were placed. b After the whole rat was frozen, the portion of the rat containing tumor (with tumor circled in yellow) was
sectioned into transverse blocks along the skin markings and placed into an airtight container. The individual sections were then frozen and then
analyzed visually for viability with preservation of orientation
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the macroscopic histological image of the tumor’s cross-
sectional surface—a two-dimentional (2D) image (as
demonstrated in Fig. 2a) with the assumption that there
was modest macroscopic variation in the distribution of
viable tumor tissues within a 1-mm thickness.
First, a pathologist reviewed the gross tumor tissue
blocks in paraffin that was processed from rat 9—the
reference rat, to identify and delineate the viable portion
of the tumor by its macroscopic morphology, and the
delineation was validated using microscopic examination
of the associated H&E stains (Fig. 3). Next, the whole
tumor area and its viable portion were delineated on
each of the 51 macroscopic histological images, without
review of the FDG-PET data. Thus, the examination of
the unstained frozen sections for the fraction of viable
tumor was informed by the detailed examination of the
macroscopic and microscopic characteristics of the
H&E-stained paraffin-embedded tissues from rat 9.
For each sectioning position, a corresponding cranial-
caudal level in the FDG-PET images was determined
using imaging bed position, and two FDG-PET slices
closest to that level were selected. Then, the rostral
FDG-PET slice was matched to the macroscopic histo-
logical image of the rostral cross-sectional surface and
the caudal PET slice to the histological image of the cau-
dal surface, thus forming two pairs of matched images
with each pair containing a FDG-PET slice and its
matched macroscopic histological image.
After each pair of matched images was established, the
FDG-PET slice was registered to the histological image
under the guidance of the fiducial markers using Amide
software (http://amide.sourceforge.net/index.html). The
macroscopic histological image acquired at 200 DPI had a
pixel size of 0.127 × 0.127 mm2, which was much smaller
than a FDG-PET slice’s axial pixel size of 1 × 1 mm2. In
order for them to co-register, the smaller pixel size was
adjusted to match the larger one, resulting in a coarser
histological image with a lower resolution, as demon-
strated in Fig. 2c, d.
Analysis of image data
Four FDG-PET tumor contouring methods were investi-
gated. The first three methods were based on fixed single
value thresholds (voxel counts in our study), and the last
method used an auto-detection algorithm (MIM software,
Cleveland, Ohio), which was based on acceleration/
deceleration of pixel intensity changes [15].
In method I, a spectrum of thresholds was determined
by using 15–90 % (in 5 % increments) of the maximum
single tumor voxel counts (Cmax) in each rat.
In method II, all 3 × 3 × 3 cubic voxel sets containing
the Cmax voxel were examined. Tumor peak counts
(Cpeak) was defined as the highest average voxel counts
among all 3 × 3 × 3 cubic voxel sets. A spectrum of
thresholds was determined using 15–90 % (in 5 % incre-
ments) of Cpeak.
In method III, a liver mean voxel count (Cliver mean)
was defined as the average voxel counts in a sphere
6 mm in diameter, located in the right upper portion of
the liver of each rat. The standard deviation (SD) of
voxel counts in the sphere (Cliver SD) was also calculated.
A spectrum of thresholds was determined by a range of
multiples of Cliver mean plus 2 × Cliver SD.
In method IV, each rat’s FDG- PET image file was
imported to the MIM workstation (Cleveland, OH), and
the “PET/SPECT edge contour” function was used to
create a 3D tumor contour. The operator had to manu-
ally seed the tumor center to start the algorithm.
In methods I–III, in each FDG-PET slice, a gross
tumor area (GTA) was generated by all pixels equal to
Fig. 2 Fused images. Co-registered images from Rat 5 in supine position, with tumor on its back. a Transverse section of the rat through limb (L),
spine (S), scapular (SC), and tumor (T). The central white portion of the tumor represents viable tumor areas, while the more peripheral red portion
of the tumor represents necrotic tumor areas with hemorrhage. b The corresponding FDG-PET image. c The fused images of a and b, where the
FDG-PET image voxel signal intensities closely correlate with the geographic distribution of the viable and necrotic tumor areas. Note the
well-overlapped fiducial markers on the dorsal aspect of the tumor. d Four gross tumor areas (GTAs) generated from variable percentages of
tumor peak voxels (Cpeak) as well as PERCIST (1.5 × Cliver mean + 2 × Cliver SD) were overlaid onto the histological image: Red represented 70 % of
Cpeak, blue represented 50 % of Cpeak, green represented 30 % of Cmax, and yellow represented the PERCIST based threshold. Among the four GTAs,
30 % Cpeak (green) best delineated the viable portion of the tumor
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or above the threshold value. In method IV, a gross tumor
volume (GTV) was automatically generated from the con-
tiguous 3D set of edge points defined by MIM software.
In each pair of co-registered FDG-PET slice and its
corresponding macroscopic histological image, different
GTAs generated from methods I–III were tested against
the viable area of the tumor in the corresponding histo-
logical image. Statistical calculations were performed
using a binary classification system with the assistance
of ImageJ (NIH) to assess each GTA’s performance on
tumor delineation (http://rsb.info.nih.gov/ij/). The GTV
contoured in method IV was analyzed separately.
Statistical calculations
We designed a binary classification system to evaluate
FDG-PET’s accuracy in contouring the viable and necrotic
portions of the tumor on a macroscopic histological
image. The test population—the areas to be tested—was
the whole tumor areas (including both viable and necrotic
potions of the tumor) delineated on the macroscopic
histological image by the pathologist (WTAH), in units of
pixels (Fig. 4a). The viable area of the tumor was
considered as condition positive (validation standard)
(Fig. 4c 5 + 6 + 7), and the necrotic area was consid-
ered as condition negative (Fig. 4c 1 + 2 + 3 + 4).
In each pair of co-registered images, different gross
tumor areas (GTAs) were generated from the FDG-PET
slice using methods I–III (Fig. 4b). Each GTA was tested
on the histological image separately. The test outcome
was positive (viable), if the histological area to be tested
was included by the GTA (Fig. 4c 3 + 4 + 5), or negative
(necrotic), if the area to be tested was not included by
the GTA (Fig. 4c 1 + 2 + 6 + 7). As the test results for
each histological area (in units of pixels) may or may not
match that area’s actual viability status, true positive was
defined as the viable areas of the tumor on the histo-
logical image that were correctly identified as viable by
the GTA (Fig. 4c 5), and true negative was defined as
the necrotic areas of the tumor that were correctly iden-
tified as necrotic (Fig. 4c 1 + 2). Sensitivity was defined
as the viable areas correctly identified by GTA (true
positive)/viable tumor areas delineated on histology
(condition positive), and specificity was defined as the
necrotic tumor areas correctly identified by GTA (true
negative)/the necrotic tumor areas delineated on hist-
ology (condition negative). Notably, only the tumor areas
on a histological image were tested in the design above.
The surrounding normal tissues were excluded from the
test population. To further evaluate the accuracy of each
GTA, GTAOE was defined as the overestimated areas in
the GTA that extended beyond the whole tumor areas
on the histological image (WTAH) into the surrounding
normal tissue and background air space (Fig. 4c 8 + 9 + 10).
Different GTAs generated from methods I–III were
applied to each of the 51 pairs of co-registered images,
and the resulting sensitivity, specificity, and GTAOE
/WTAH ratio (in percentage) were calculated. A receiver
Fig. 3 Pathological specimen. a A paraffin tumor tissue block with
central necrosis (marked in yellow square) from reference rat 9 (Top)
and its corresponding H&E stain (bottom). b The center of the H&E
stain in ×20 magnification. There is a pathological correlation
between the necrotic center on the H&E stain and the macroscopic
morphology of the central necrosis (marked in yellow square) in the
tissue block in Fig. 2a. c The center of the H&E stain in ×80
magnification. The central necrotic area consists of hemorrhage, cell
debris, and neutrophil infiltration
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operating characteristic curve (ROC curve), which illus-
trated each contouring method’s performance on tumor
delineation for each pair of co-registered images, was
plotted using sensitivity and 1-specificity as x and y axes,
respectively, with its area under the curve (AUC) ap-
proximated using the Gini coefficient (Fig. 5) [16]. Be-
cause in any particular pair of images, the GTAs
generated from all three methods were all based on sin-
gle value threshold (voxel counts) from the same FDG-
PET slice, there was only one ROC curve for each image
pair. In other words, in any particular pair of images, the
ROC curves plotted from each of the three methods
overlapped and complimented one another.
The generalized estimating equations (GEE) method
was used to estimate the mean and standard error of the
measurements, accounting for the correlations of the
two cross-sectional surfaces from a single transverse sec-
tioning [17]. Standard error of the mean (SE) and 95 %
confidence intervals (CIs) were computed based on
10,000 bootstrap samples.
Results and discussion
In methods I–III, the means and 95 % CI of the sensitiv-
ity, specificity, and GTAOE /WTAH ratio from 51 pairs
of images were calculated for each GTA generated from
each contouring method, respectively (Tables 1, 2, and
3). The ROC curves of all pairs of images have a mean
AUC of 0.934 (CI of 0.911–0.954). The means and 95 %
CIs of the sensitivity and GTAOE/WTAH ratio of GTAs
generated from each of the three methods were plotted
in Fig. 6a–c, respectively.
In method IV, the resulting GTV using MIM’s “PET
edge” function was not reproducible. Depending on the
position where the seed point was chosen and the direc-
tion it was dragged, the resulting tumor delineations
were different (Fig. 6d).
Our study uses immunologically intact rats, which resem-
ble human tumors in vivo. As animal irradiation systems
become more common, more precise contouring methods
of animal tumors are of experimental importance.
Our study demonstrates that single value threshold
tumor contouring method using 18F-FDG-PET can reli-
ably delineate the viable portion of a tumor, as illustrated
by a mean AUC of 0.934 (CI of 0.911–0.954) (Fig. 5).
There is some variation among the eight rats in the sen-
sitivities and specificities calculated from the same
threshold percentage using the same contouring method,
as illustrated by the confidence intervals in Tables 1, 2,
Fig. 4 Binary classification system. A schematic diagram of our binary classification system: FDG-PET tumor contouring in a certain pair of co-registered
images at a certain threshold value derived from a certain contouring method. a Macroscopic histological image representing a tumor with central and
peripheral necrosis. The areas to be tested by FDG-PET are composed of both viable and non-viable portions of the tumor. Notably, the surrounding
normal tissues are not included in the tested areas at this stage. b Gross tumor area (GTA) generated from a certain FDG-PET threshold value. c The
fused image of a and b. Areas 8, 9, and 10 represent the overestimated areas in the GTA extending into the surrounding normal tissue and background
air space
Fig. 5 ROC curves. Eighteen ROC curves corresponding to 18 pairs of co-registered images from three representative rats are demonstrated here.
The legend on the right of each illustration indicates the number of sectioning, the rostral/caudal surface (a/b), and the corresponding FDG-PET
slice number
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and 3. A possible explanation is the influence of tissue
viability heterogeneity on the FDG-PET voxel counts. A
single threshold value in the necrotic portion of a tumor
may exclude the adjacent very thin rim of viable tumor
areas, and very small tumor areas beyond the spatial
resolution of micro-PET may not be contoured [18].
In our study, sensitivity represented how well a FDG-
PET generated GTA included the viable tumor area de-
lineated on histology. Fifty percent sensitivity indicated
that 50 % of the viable tumor area was covered by the
GTA. In radiotherapy planning, a high sensitivity is de-
sired to irradiate most, if not all viable tumor volumes.
Specificity represented how well a GTA managed to
stay within the viable tumor area, without extending into
the adjacent necrotic tumor area. In radiotherapy plan-
ning, a more selective radiation field may reduce the
dose to surrounding normal tissue. An interesting ques-
tion to ask is the effect of irradiating the necrotic tumor
tissue contoured by FDG-PET on whole tumor growth.
One common concern during radiotherapy is the pos-
sibility of irradiating the normal structures surrounding
the tumor target. This issue is difficult to address by
simple statistical analysis, because it is influenced by
many factors including the size, shape, and location of
the tumor target and the radiation sensitivities of the
tumor and surrounding tissues. In our study, we used
GTAOE/WTAH ratio to illustrate the extent to which a
particular GTA extended into the normal structures sur-
rounding the primary tumor target.
The most desirable contouring method for radiother-
apy planning would have a sensitivity (and to a lesser de-
gree, a specificity) close to 100 %, with a GTAOE/WTAH
ratio close to 0 %. In our study, a common characteristic
demonstrated in Fig. 6 was that as the threshold value of
a particular contouring method decreases, its sensitivity
is increased at the expense of an increased GTAOE/
WTAH ratio. That being said, certain threshold values
achieved a sensitivity greater than 90 % with a GTAOE/
WTAH ratio less than 10 %: 30 % and 35 % of both max-
imal tumor voxel activity (Cmax) and tumor peak activity
(Cpeak). These threshold values can be considered in cre-
ating gross tumor volume in radiotherapy planning re-
quiring broad tumor coverage with relatively high
priority of adjacent normal tissue preservation. Tumor
Table 1 Method I—percentage of maximal voxel activity
Cmax(%) Sensitivity (CI) Specificity (CI) GTAOE/WTAH (CI)
15 99.9 % (99.8–100.0 %) 36.3 % (25.9–46.8 %) 25.0 % (20.4–29.9 %)
20 99.4 % (99.1–99.7 %) 50.4 % (39.7–60.7 %) 16.7 % (13.2–20.5 %)
25 98.1 % (97.4–98.8 %) 61.1 % (51.6–70.2 %) 11.3 % (8.7–14.1 %)
30 95.3 % (93.9–96.6 %) 70.9 % (62.7–78.6 %) 7.5 % (5.5–9.8 %)
35 91.3 % (89.2–93.3 %) 77.5 % (70.3–84.2 %) 5.0 % (3.4–6.7 %)
40 85.3 % (82.3–88.2 %) 84.1 % (78.3–89.3 %) 3.1 % (2.0–4.4 %)
45 77.3 % (73.8–80.6 %) 90.0 % (85.8–93.8 %) 1.9 % (1.2–2.7 %)
50 67.2 % (62.9–71.4 %) 93.4 % (90.4–96.2 %) 1.1 % (0.6–1.7 %)
70 23.6 % (19.4–28.4 %) 99.4 % (98.9–99.8 %) 0.1 % (0.0–0.1 %)
90 3.7 % (2.3–5.4 %) 100.0 % (100.0–100.0 %) 0.0 % (0.0–0.0 %)
CI confidence interval, GTAOE gross tumor area overestimate, WTAH whole tumor areas on histology
Table 2 Method II—percentage of tumor peak activity
Cpeak (%) Sensitivity (CI) Specificity (CI) GTAOE/WTAH (CI)
15 100.0 % (99.9–100.0 %) 32.2 % (23.0–42.2 %) 28.3 % (23.0–33.8 %)
20 99.6 % (99.4–99.8 %) 46.9 % (36.1–57.4 %) 18.9 % (15.0–23.0 %)
25 98.7 % (98.1–99.2 %) 57.4 % (47.2–67.1 %) 13.3 % (10.3–16.5 %)
30 96.9 % (95.9–97.8 %) 66.0 % (57.1–74.5 %) 9.3 % (7.0–11.8 %)
35 93.7 % (92.0–95.3 %) 73.8 % (65.8–81.1 %) 6.3 % (4.5–8.3 %)
40 89.0 % (86.4–91.5 %) 80.2 % (73.2–86.5 %) 4.2 % (2.8–5.8 %)
45 83.1 % (79.8–86.1 %) 86.3 % (80.9–91.2 %) 2.7 % (1.8–3.8 %)
50 75.6 % (72.0–79.1 %) 90.8 % (86.5–94.6 %) 1.7 % (1.1–2.5 %)
70 34.1 % (29.5–38.9 %) 98.9 % (98.0–99.6 %) 0.1 % (0.0–0.2 %)
90 8.4 % (5.5–11.6 %) 99.9 % (99.7–99.9 %) 0.0 % (0.0–0.0 %)
CI confidence interval, GTAOE gross tumor area overestimate, WTAH whole tumor areas on histology
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contouring using 50 % of Cmax or Cpeak – commonly re-
ported threshold values in the literature, had relatively
low sensitivities of 67.2 %–75.6 % with very low GTAOE/
WTAH ratios of 1.1 %–1.7 %, and may be considered in
sub-volume boosting, where a high dose of radiation is
prescribed to the most metabolically active region of the
tumor.
Successful radiotherapy decreases peak tumor activity,
while the liver radioactivity is expected to remain relatively
constant [19]. Tumor contouring methods based on liver
activity, therefore, potentially could be particularly helpful
in post-radiation re-planning situations. Tumor contour-
ing based on PERCIST with 1.5 × Cliver mean + 2 × SD had
a sensitivity of 100 % but a high GTAOE/WTAH ratio of
50.5 % (CI 42.7–59.1) [20]. Tumor contouring using 6 ×
Cliver mean + 2 × SD had a sensitivity of 95.1 % (CI 93.5–
96.5) and a GTAOE/WTAH ratio of 7.4 % (CI 5.6–9.5 %),
which was comparable to contouring using 30 and 35 %
of Cmax or Cpeak, and may be considered in radiotherapy
planning where prior radiation was performed.
Although our study was limited to mammary tumor in
an animal model, it provided a template approach to
perform similar studies with other tumor types using dif-
ferent radiotracers. As more radiotracers become avail-
able, similar studies can be performed to facilitate their
application in clinical settings. For example, such an
approach could be used in 18F-fluoromisonidazole(F-
MISO)-PET to evaluate how FMISO characterizes tumor
tissue hypoxia in vivo in animal model and provide a
roadmap for further research on FMISO-based radio-
therapy planning [21].
Several issues need to be discussed. The first issue
regards the variation between macroscopic and micro-
scopic pathologies. The frankly necrotic portion of a
tumor is easy to differentiate macroscopically from the
viable portion. However, the gray zone in between,
where there is a mixture of tumor cells, immunological
cells, and cell debris, is difficult to identify on macro-
scopic images. To be conservative, we included these
areas in the viable portion of the tumor, although the
clinical importance of these areas needs further research.
The second issue is related to the limitation of our
imaging system. The spatial resolution of the animal
micro-PET scanner is approximately 2 mm [12]. With a
typical cell diameter at tens of microns, failure to detect
small tumors is possible. This limits the accuracy of the
data analysis, especially when the tumors are small. Our
data analysis is also limited by partial volume effect,
which is more prominent in small tumors. Utilizing re-
construction algorithm designed to improve image-space
resolution, e.g., resolution modeling during reconstruc-
tion, could help to improve the quality of our PET im-
aging and decrease partial volume effect [22].
The third issue is that tumors vary substantially in
their metabolic activities. Our tumor model has rela-
tively high FDG uptake, and the variability in voxel
counts may affect the optimal threshold for tumor con-
touring. In fact, FDG-PET tumor contouring may even
be tumor specific, and human tumors may have lower
FDG uptake.
Finally, the contouring methods investigated in our
study are based on single value threshold. It is worth de-
bating whether tumor volume is best delineated with
single value. Our last method using an edge detection
technique was an attempt to evaluate the performance
of a non-single-value contouring method. However, due
to the system’s lack of reproducibility, we were unable to
reliably analyze the data. A potential future study is to
investigate non-single-value contouring algorithms de-
veloped by other groups, compare their results to those
obtained in this study, and explore other edge detection
methods. In addition, CT-based tumor contouring,
which is usually performed in clinical settings, was not
investigated for comparison to PET-based contouring
methods in our study. This is due to technical difficulty
in acquiring an intravenously enhanced CT imaging of a
rat while maintaining its anatomic orientation between
two different imaging beds. Hybrid small animal PET/
CT or PET/MR may provide better soft tissue
characterization and additional useful information.
Conclusions
Single-value threshold tumor contouring using 18F-FDG-
PET is able to accurately delineate the viable portion of a
tumor in this rodent model and provide an imaging blue-
print to future animal radiotherapy planning studies
Table 3 Method III—multiple of liver mean activity + 2 × standard deviation (SD))
Multiple of liver mean Sensitivity (CI) Specificity (CI) GTAOE/WTAH (CI)
1.5 100.0 % (100.0–100.0 %) 11.9 % (6.9–17.7 %) 50.5 % (42.7–59.1 %)
3 99.9 % (99.7–100.0 %) 36.9 % (26.8–47.1 %) 24.4 % (20.0–29.2 %)
4 99.3 % (98.8–99.6 %) 50.8 % (40.4–60.6 %) 16.2 % (13.0–19.8 %)
5 97.8 % (96.8–98.6 %) 62.1 % (53.0–70.7 %) 11.1 % (8.7–13.9 %)
6 95.1 % (93.5–96.5 %) 71.2 % (63.4–78.5 %) 7.4 % (5.6–9.5 %)
7 90.7 % (88.1–93.2 %) 78.1 % (71.5–84.3 %) 5.1 % (3.7–6.9 %)
CI confidence interval, GTAOE gross tumor area overestimate, WTAH whole tumor areas on histology
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seeking dose efficiency and reduction. Our study design
may also provide a template approach to radiotracer valid-
ation in small animals and help to inform future clinical
studies. While human tumors no doubt differ, our study
suggests threshold values of 30 and 35 % of Cmax or Cpeak
and 6 × Cliver + 2 × SD are all appropriate for delineating
viable tumor volume in a rodent breast cancer model.
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Fig. 6 Sensitivity and GTAOE/WTAH curves from methods I–III and MIM
contouring in method IV. a–c The sensitivity and GTAOE/WTAH were
plotted against linear increment in threshold values derived from
methods I–III, respectively. In each plot, the means were plotted in a
darker line with data points, accompanied by the 95 % confidence
intervals plotted in a thinner line without data points. d FDG-PET
image of rat 5 was loaded into the MIM system as described in
method IV. Two tumor contouring attempts (ROI blue and ROI
magenta) using PET/SPECT edge contour function were demonstrated
in axial (right), sagittal (middle), and coronal (left) planes. The two
attempts were initiated with different seed points and yielded two
inconsistent gross tumor volumes. GTAOE the overestimated area in the
gross tumor area, WTAH whole tumor area on histology
Wu et al. EJNMMI Research  (2015) 5:58 Page 9 of 10
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